The third pathway is to induce tumor cell apoptosis by limiting tumor angiogenesis and enhancing adaptive immunity by releasing effector molecules with anti-cancer properties, such as interferon-γ (IFN-γ) (29, 34). Here, IFNG is linked to neoplasm.